The factory, scheduled to come into operation in October 2010, will be equipped with technology and machinery provided by US Affordable Quality Pharmaceuticals (AQP).
The US $3.2-million factory will churn out drugs for cancer, diabetes, hypertension, and heart-disease treatment.
Danosoma is a joint-venture between Vietnamese Pharmaceutical Corp (Vinapharm) holding 25% of stakes, the US Danapha 51% and AQP 24%.
By Hải Minh